JP2022539401A5 - - Google Patents
Info
- Publication number
- JP2022539401A5 JP2022539401A5 JP2021578069A JP2021578069A JP2022539401A5 JP 2022539401 A5 JP2022539401 A5 JP 2022539401A5 JP 2021578069 A JP2021578069 A JP 2021578069A JP 2021578069 A JP2021578069 A JP 2021578069A JP 2022539401 A5 JP2022539401 A5 JP 2022539401A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocycloalkyl
- cycloalkyl
- hydrogen
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962870744P | 2019-07-04 | 2019-07-04 | |
| US62/870,744 | 2019-07-04 | ||
| US201962928838P | 2019-10-31 | 2019-10-31 | |
| US62/928,838 | 2019-10-31 | ||
| US202062966411P | 2020-01-27 | 2020-01-27 | |
| US62/966,411 | 2020-01-27 | ||
| PCT/CA2020/050933 WO2021000054A1 (en) | 2019-07-04 | 2020-07-03 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022539401A JP2022539401A (ja) | 2022-09-08 |
| JP2022539401A5 true JP2022539401A5 (enExample) | 2025-02-28 |
Family
ID=74100114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021578069A Ceased JP2022539401A (ja) | 2019-07-04 | 2020-07-03 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220242844A1 (enExample) |
| EP (1) | EP3994129A4 (enExample) |
| JP (1) | JP2022539401A (enExample) |
| WO (1) | WO2021000054A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022540586A (ja) | 2019-07-12 | 2022-09-16 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12252503B2 (en) | 2019-07-12 | 2025-03-18 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| WO2021102567A1 (en) | 2019-11-26 | 2021-06-03 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| EP4073053A4 (en) * | 2019-12-09 | 2023-11-22 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| US12240813B2 (en) | 2020-05-19 | 2025-03-04 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CN113801126A (zh) * | 2021-07-20 | 2021-12-17 | 云南大学 | 一种多取代吡啶衍生物及其制备方法 |
| WO2026038872A1 (ko) * | 2024-08-13 | 2026-02-19 | 주식회사 네오켄바이오 | 신규한 화합물 및 이의 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017250303B2 (en) * | 2016-04-15 | 2019-09-26 | Teewinot Technologies Limited | Biosynthesis of cannabinoid prodrugs |
| JP2021535203A (ja) * | 2018-08-20 | 2021-12-16 | ベッソール ファルマ、エルエルシー | 既知および新規カンナビノイドの適用 |
-
2020
- 2020-07-03 WO PCT/CA2020/050933 patent/WO2021000054A1/en not_active Ceased
- 2020-07-03 JP JP2021578069A patent/JP2022539401A/ja not_active Ceased
- 2020-07-03 US US17/624,589 patent/US20220242844A1/en not_active Abandoned
- 2020-07-03 EP EP20828951.2A patent/EP3994129A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539401A5 (enExample) | ||
| JP2022539400A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| JP2022551067A5 (enExample) | ||
| JP2023505513A5 (enExample) | ||
| JP2022540585A5 (enExample) | ||
| JP2022540433A5 (enExample) | ||
| JP2022540586A5 (enExample) | ||
| JP2023503331A5 (enExample) | ||
| JP4669564B2 (ja) | ２−イミノ−チアゾリジン−４−オン誘導体の製造のための新規な方法 | |
| JP2022540434A5 (enExample) | ||
| JP2023503601A5 (enExample) | ||
| JP2012522793A5 (enExample) | ||
| JP2010520264A5 (enExample) | ||
| JP2018529687A5 (enExample) | ||
| JP2025509088A (ja) | Ｎｌｒｐ３の阻害剤 | |
| JP2013521291A5 (enExample) | ||
| AR074184A1 (es) | Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah | |
| JP2015508092A5 (enExample) | ||
| JP2023543254A5 (enExample) | ||
| JP2011500818A5 (enExample) | ||
| JP2010509334A5 (enExample) | ||
| JP2015502371A5 (enExample) | ||
| JP2023507569A5 (enExample) | ||
| JP2025509635A5 (enExample) |